Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aman P Singh

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
The AAPS Journal|April 5, 2017
Application of a PK-PD Modeling and Simulation-Based Strategy for Clinical Translation of Antibody-Drug Conjugates: a Case Study with Trastuzumab Emtansine (T-DM1)Aman P Singh, Dhaval K Shah
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 20, 2017
Measurement and Mathematical Characterization of Cell-Level Pharmacokinetics of Antibody-Drug Conjugates: A Case Study with Trastuzumab-vc-MMAEAman P Singh, Dhaval K Shah
Journal of Pharmaceutical Sciences|February 22, 2019
A "Dual" Cell-Level Systems PK-PD Model to Characterize the Bystander Effect of ADCAman P Singh, Dhaval K Shah
Clinical and Translational Science|February 12, 2025
Mechanistic Evaluation of Anti-CD19 CAR-T Cell Therapy Repurposed in Systemic Lupus Erythematosus Using a Quantitative Systems Pharmacology ModelHyunseo Park, Ganesh M Mugundu, Aman P Singh
Journal of Pharmacokinetics and Pharmacodynamics|September 28, 2016
Quantitative characterization of in vitro bystander effect of antibody-drug conjugatesAman P Singh, Sharad Sharma, Dhaval K Shah
CPT: Pharmacometrics & Systems Pharmacology|July 14, 2023
Development of a multiscale mechanistic modeling framework integrating differential cellular kinetics of CAR T-cell subsets and immunophenotypes in cancer patientsAhmed M Salem, Ganesh M Mugundu, Aman P Singh
Clinical and Translational Science|December 19, 2024
Translational PK-PD model for in vivo CAR-T-cell therapy delivered using CAR mRNA-loaded polymeric nanoparticle vectorSe Jin Kim, Ganesh M Mugundu, Aman P Singh
Pharmaceutical Research|February 11, 2015
Application of Pharmacokinetic-Pharmacodynamic Modeling and Simulation for Antibody-Drug Conjugate DevelopmentAman P Singh, Young G Shin, Dhaval K Shah
Frontiers in Pharmacology|April 26, 2018
Dynamics of Erythropoietic Biomarkers in Response to Treatment With Erythropoietin in Belgrade RatsLy M Nguyen, Aman P Singh, Pawel Wiczling, et al.
Journal of Pharmacokinetics and Pharmacodynamics|July 22, 2022
Development of minimal physiologically-based pharmacokinetic-pharmacodynamic models for characterizing cellular kinetics of CAR T cells following local deliveries in miceChia-Hung Tsai, Aman P Singh, Cindy Q Xia, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
The AAPS Journal|April 5, 2017
Application of a PK-PD Modeling and Simulation-Based Strategy for Clinical Translation of Antibody-Drug Conjugates: a Case Study with Trastuzumab Emtansine (T-DM1)Aman P Singh, Dhaval K Shah
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 20, 2017
Measurement and Mathematical Characterization of Cell-Level Pharmacokinetics of Antibody-Drug Conjugates: A Case Study with Trastuzumab-vc-MMAEAman P Singh, Dhaval K Shah
Journal of Pharmaceutical Sciences|February 22, 2019
A "Dual" Cell-Level Systems PK-PD Model to Characterize the Bystander Effect of ADCAman P Singh, Dhaval K Shah
Clinical and Translational Science|February 12, 2025
Mechanistic Evaluation of Anti-CD19 CAR-T Cell Therapy Repurposed in Systemic Lupus Erythematosus Using a Quantitative Systems Pharmacology ModelHyunseo Park, Ganesh M Mugundu, Aman P Singh
Journal of Pharmacokinetics and Pharmacodynamics|September 28, 2016
Quantitative characterization of in vitro bystander effect of antibody-drug conjugatesAman P Singh, Sharad Sharma, Dhaval K Shah
CPT: Pharmacometrics & Systems Pharmacology|July 14, 2023
Development of a multiscale mechanistic modeling framework integrating differential cellular kinetics of CAR T-cell subsets and immunophenotypes in cancer patientsAhmed M Salem, Ganesh M Mugundu, Aman P Singh
Clinical and Translational Science|December 19, 2024
Translational PK-PD model for in vivo CAR-T-cell therapy delivered using CAR mRNA-loaded polymeric nanoparticle vectorSe Jin Kim, Ganesh M Mugundu, Aman P Singh
Pharmaceutical Research|February 11, 2015
Application of Pharmacokinetic-Pharmacodynamic Modeling and Simulation for Antibody-Drug Conjugate DevelopmentAman P Singh, Young G Shin, Dhaval K Shah
Frontiers in Pharmacology|April 26, 2018
Dynamics of Erythropoietic Biomarkers in Response to Treatment With Erythropoietin in Belgrade RatsLy M Nguyen, Aman P Singh, Pawel Wiczling, et al.
Journal of Pharmacokinetics and Pharmacodynamics|July 22, 2022
Development of minimal physiologically-based pharmacokinetic-pharmacodynamic models for characterizing cellular kinetics of CAR T cells following local deliveries in miceChia-Hung Tsai, Aman P Singh, Cindy Q Xia, et al.
Pageof 4